Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.

BMJ (Clinical research ed.)

Volumn 312, Issue 7032, 1996, Pages

  Gerlach, M ^a   Riederer, P ^a   Vogt, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA; SELEGILINE;

DRUG COMBINATION; HUMAN; METHODOLOGY; MORTALITY; NOTE; PARKINSON DISEASE;

ANTIPARKINSON AGENTS; DRUG THERAPY, COMBINATION; HUMANS; LEVODOPA; PARKINSON DISEASE; RESEARCH DESIGN; SELEGILINE;

EID: 0030589922     PISSN: 09598138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)